HealthWarehouse.com EV/EBITDA
The EV/EBITDA (Enterprise Value to EBITDA) of HealthWarehouse.com (HEWA) as of Aug 1, 2026 is 11.91. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -547.99 — a change of -102.17% (higher).
Get this data via API
Financial Data API
EV/EBITDA
11.91
YoY
-102.17%
Last updated:
EV/EBITDA (Enterprise Value to EBITDA) of HealthWarehouse.com is 2026 11.91 . EV/EBITDA (Enterprise Value to EBITDA) of HealthWarehouse.com was 2025 -547.99 . It decreases by -102.17% higher compared to the previous year.
Access this data via the Eulerpool API
HealthWarehouse.com Stock analysis
What does HealthWarehouse.com do? HealthWarehouse.com Inc is a Kentucky-based company that operates as an online pharmacy, offering a wide range of prescription and over-the-counter medications, health and wellness products, medical devices, and accessories. The company was founded in 2007 by Joseph Peters with the goal of making access to medications and health products easier by making them available online in a simple and convenient way. HealthWarehouse.com Inc obtained its official license as an online pharmacy in 2008 and began operating. The company focuses on providing high-quality products at affordable prices and utilizes innovative technologies to offer a fast, safe, and reliable service that meets the needs of customers worldwide. HealthWarehouse.com Inc concentrates on providing a comprehensive and convenient way to meet the demand for medical products and supplies from the comfort of one's home. The company operates in five main divisions: Prescription Drugs, Medical Devices, Over-The-Counter Medications, Pet Medications, and Health Products. It offers various products from different brands, including generic and brand-name drugs, as well as a wide range of medical devices and accessories. HealthWarehouse.com Inc is a preferred choice for customers seeking a practical and affordable alternative for purchasing medications and health products. HealthWarehouse.com is one of the most popular companies on Eulerpool.
Frequently Asked Questions about HealthWarehouse.com stock
EV/EBITDA (Enterprise Value to EBITDA) of HealthWarehouse.com is 11.91 in 2026.
Access this data via the Eulerpool API
Valuation — HealthWarehouse.com
All Key Metrics — HealthWarehouse.com
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth